|
ACTR10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.158900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.198300E-03 |
| Normal-vs-Stage2 |
1.602630E-01 |
| Normal-vs-Stage3 |
7.207500E-04 |
| Normal-vs-Stage4 |
5.57970000000241E-05 |
| Stage1-vs-Stage2 |
5.340000E-01 |
| Stage1-vs-Stage3 |
1.774640E-01 |
| Stage1-vs-Stage4 |
2.119700E-02 |
| Stage2-vs-Stage3 |
1.434620E-01 |
| Stage2-vs-Stage4 |
1.909990E-02 |
| Stage3-vs-Stage4 |
2.483600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.019300E-04 |
| Normal-vs-AfricanAmerican |
5.303600E-01 |
| Normal-vs-Asian |
5.608000E-02 |
| Caucasian-vs-AfricanAmerican |
1.248180E-01 |
| Caucasian-vs-Asian |
3.311600E-01 |
| AfricanAmerican-vs-Asian |
4.303200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.428670E-04 |
| Normal-vs-Female |
5.878500E-03 |
| Male-vs-Female |
3.172500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.438490E-02 |
| Normal-vs-Age(41-60Yrs) |
1.758760E-03 |
| Normal-vs-Age(61-80Yrs) |
1.280120E-03 |
| Normal-vs-Age(81-100Yrs) |
5.430300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.503200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.074800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.018000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.245000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.586000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.247800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.551400E-01 |
| Classical-VS-Follicular |
9.097600E-01 |
| Classical-VS-Other |
3.037200E-01 |
| Classical-VS-Normal |
1.289660E-02 |
| Tall-VS-Follicular |
3.633000E-01 |
| Tall-VS-Other |
6.824800E-01 |
| Tall-VS-Normal |
4.421300E-03 |
| Follicular-VS-Other |
4.571000E-01 |
| Follicular-VS-Normal |
3.510000E-02 |
| Other-VS-Normal |
3.721600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.915600E-03 |
| Normal-vs-N1 |
1.365060E-04 |
| N0-vs-N1 |
4.110400E-02 |
|
|
